H1N1 pandemic influenza virus vaccine (Sinovac Biotech)

甲型H1N1流感病毒裂解疫苗（科兴生物）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameH1N1 pandemic influenza virus vaccine (Sinovac Biotech)
Drug Alias Name大流行流感病毒裂解疫苗(甲型H1N1)（科兴生物）Influenza A (H1N1) vaccine - Sinovac Biotech大流行流感病毒裂解疫苗（科兴生物）Swine flu vaccine - Sinovac BiotechPanflu.1 +[6] 
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > National Immunization Program > Non-immunization program vaccine(Class II) +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2009/09/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSinovac Biotech Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesSinovac Biotech Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB
Related LinksN/A